Literature DB >> 25473094

Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.

Hiromi Fujita1,2, Yutaka Hatanaka1, Yoichi Sutoh1,2, Yuta Suzuki1, Koji Oba3, Kanako C Hatanaka1, Tomoko Mitsuhashi1, Noriyuki Otsuka2, Kazunori Fugo2, Masanori Kasahara2, Yoshihiro Matsuno1.   

Abstract

The MHC class I-chain-related proteins (MICs) and the UL16-binding proteins (ULBPs) are inducible stress response molecules that work as activators of a specific receptor, NKG2D, which is expressed on effector cells, such as NK cells and subsets of T cells. In this study, we sought to explore the biological significance of NKG2D ligands in human neoplasms by comprehensively examining the immunohistochemical expression profile of NKG2D ligands in a variety of human epithelial neoplasms. Following careful validation of the immunohistochemical specificity and availability of anti-human ULBP antibodies for formalin-fixed paraffin-embedded (FFPE) materials, the expression of NKG2D ligands was analyzed in FFPE tissue microarrays comprising 22 types of epithelial neoplastic tissue with their non-neoplastic counterpart from various organs. Hierarchical cluster analysis demonstrated a positive relationship among ULBP2/6, ULBP3, ULBP1, and ULBP5, whose expression patterns were similar across all of the neoplastic tissues examined. In contrast, MICA/B, as well as ULBP4, did not appear to be related to any other ligand. These expression profiles of NKG2D ligands in human neoplasms based on well-validated specific antibodies, followed by hierarchical cluster analysis, should help to clarify some functional aspects of these molecules in cancer biology, and also provide a path to the development of novel tumor-type-specific treatment strategies.
© The Author(s) 2015.

Entities:  

Keywords:  NKG2D ligands; epithelial neoplasms; immunohistochemistry

Mesh:

Substances:

Year:  2014        PMID: 25473094      PMCID: PMC4340732          DOI: 10.1369/0022155414563800

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  33 in total

1.  Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.

Authors:  Atsushi Inagaki; Takashi Ishida; Hiroki Yano; Toshihiko Ishii; Shigeru Kusumoto; Asahi Ito; Masaki Ri; Fumiko Mori; Jianmin Ding; Hirokazu Komatsu; Shinsuke Iida; Ryuzo Ueda
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

2.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.

Authors:  Stephan Gasser; Sandra Orsulic; Eric J Brown; David H Raulet
Journal:  Nature       Date:  2005-07-03       Impact factor: 49.962

Review 3.  The role of the NKG2D receptor for tumor immunity.

Authors:  Jérôme D Coudert; Werner Held
Journal:  Semin Cancer Biol       Date:  2006-07-08       Impact factor: 15.707

4.  Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.

Authors:  Nicholas F S Watson; Ian Spendlove; Zahra Madjd; Roger McGilvray; Andrew R Green; Ian O Ellis; John H Scholefield; Lindy G Durrant
Journal:  Int J Cancer       Date:  2006-03-15       Impact factor: 7.396

5.  Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.

Authors:  Katrine L Henriksen; Birgitte B Rasmussen; Anne E Lykkesfeldt; Susann Møller; Bent Ejlertsen; Henning T Mouridsen
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

6.  Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.

Authors:  Akio Takada; Shigeru Yoshida; Mizuho Kajikawa; Yukiko Miyatake; Utano Tomaru; Masaharu Sakai; Hitoshi Chiba; Katsumi Maenaka; Daisuke Kohda; Kazunori Fugo; Masanori Kasahara
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.

Authors:  Roberta Castriconi; Alessandra Dondero; Francesca Negri; Francesca Bellora; Paolo Nozza; Barbara Carnemolla; Alessandro Raso; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

8.  Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin.

Authors:  Michael I Whang; Nadia Guerra; David H Raulet
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer.

Authors:  Sonja Textor; Matthias Dürst; Lars Jansen; Rosita Accardi; Massimo Tommasino; Marcus J Trunk; Angel Porgador; Carsten Watzl; Lutz Gissmann; Adelheid Cerwenka
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

10.  Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.

Authors:  Robert A Eagle; Gillian Flack; Anthony Warford; Jesús Martínez-Borra; Insiya Jafferji; James A Traherne; Maki Ohashi; Louise H Boyle; Alexander D Barrow; Sophie Caillat-Zucman; Neil T Young; John Trowsdale
Journal:  PLoS One       Date:  2009-02-18       Impact factor: 3.240

View more
  4 in total

1.  Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.

Authors:  Eric Alves; Emily McLeish; Pilar Blancafort; Jerome D Coudert; Silvana Gaudieri
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

2.  Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.

Authors:  Kensuke Shiraishi; Kousaku Mimura; Ley-Fang Kua; Vivien Koh; Lim Kee Siang; Shotaro Nakajima; Hideki Fujii; Asim Shabbir; Wei-Peng Yong; Jimmy So; Seiichi Takenoshita; Koji Kono
Journal:  J Gastroenterol       Date:  2016-03-22       Impact factor: 7.527

3.  Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells.

Authors:  Thu Le Trinh; Wendy M Kandell; Sarah S Donatelli; Nhan Tu; Melba M Tejera; Danielle L Gilvary; Erika A Eksioglu; Alexis Burnette; William A Adams; Jinhong Liu; Jamie K Teer; Julie Y Djeu; Domenico Coppola; Sheng Wei
Journal:  Oncoimmunology       Date:  2019-01-17       Impact factor: 8.110

4.  Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8+ T-Cell Behaviors.

Authors:  Ana Carmena Moratalla; Yves Carpentier Solorio; Florent Lemaitre; Negar Farzam-Kia; Annie Levert; Stephanie E J Zandee; Boaz Lahav; Jean Victor Guimond; Elie Haddad; Marc Girard; Pierre Duquette; Catherine Larochelle; Alexandre Prat; Nathalie Arbour
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.